Christopher Verni is General Counsel at Vigil Neuroscience, Inc. (VIGL). They have made 1 open-market trade across 1 company since 2022, most recently 2022-05-03.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIGL | 4,000 | $32K |
Shares reported on the most recent Form 4, priced at the 2022-05-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIGL | BUY | 2022-05-03 | 2022-05-04 | $3.77 | $15K | -26.0% | -11.9% | +71.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.